Media

Approved via the EU Decentralised Procedure (DCP) led by the Netherlands with Germany as reference member state, filed in 2021, Guangzhou Hairui’s Parecoxib Sodium for Injection has recently obtained marketing authorization in Germany. Another key EU market access achieved. Every step forward reflects solid strength.Pressing ahead steadily! The Group’s global footprint for Parecoxib Sodium for Injection is rapidly expanding with clear results. To date, agreements cover over 20 countries; 9 (incl

Recently, the 27th World Meeting on Sexual Medicine ( “WMSM” or “the Meeting”) was held in Porto, Portugal. As a highly influential global academic event in the medical field, the congress brought together more than 1,200 experts and scholars from 41 countries, with a total of 940 academic abstracts accepted. The Class 1 innovative drug Tolonadaf Hydrochloride Tablets (brand name: Taituotuo®), independently developed by Yangtze River Pharmaceutical Group ( “YRPG” or “the Group” ), made its debut

Recently, the 15th Philanthropy Festival and 2025 ESG Summit were held in Beijing. Yangtze River Pharmaceutical Group Co., Ltd. ( “YRPG” or “the Group” ) was awarded both the "2025 Model Enterprise for Responsibility in Healthcare" and the "2025 ESG Case of the Year" in recognition of its long-term commitment and practical initiatives in healthcare responsibility and public welfare.The Philanthropy Festival, the country’s first festival themed “public welfare” and co-launched by mainstream publi

On December 17, a caring team from Yangtze River Pharmaceutical Group Co., Ltd. ( “YRPG” or “the Group” ), led by key executives Cai Wei and Tan Guangzhao arrived in Laos to launch the “Health for all, all for Health” initiative at Mahosot General Hospital in Vientiane. The team included representatives from Yangtze River Import and Export Co., Ltd., the Great Health Sector, Marketing Department, and Brand and Publicity Department. This health mission reflects the Group’s commitment to its corpo

On November 17th (local time), at the press center of the 30th Conference of the Parties to the United Nations Framework Convention on Climate Change (COP30) held in Belém, Brazil, the Publicity and Education Center of the Ministry of Ecology and Environment, together with the China Champions for Climate Action, held the launch event of 2025 Beautiful China · Green Space Users Case Collection (hereinafter referred to as the "Case Collection") . Among the 40 selected cases, Yangtze River Pharmace

On November 5th, at the 50th International Convention on Quality Control Circles (ICQCC), Yangtze River Pharmaceutical Group (referred to as YRPG) stood out from nearly 600 participating projects worldwide with its fruitful achievements in quality management research. It won 5 gold medals and 1 silver medal in one fell swoop, setting a brilliant record for Chinese enterprises at this year’s "Quality Olympics".ICQCC is an influential international conference in the field of quality management, fe

October 28–31, 2025, Yangtze River Pharmaceutical Group Co., Ltd ( the Group) participated in CPHI(Chemical and Pharmaceutical International Exhibition) Worldwide in Frankfurt, Germany, conducting friendly and pleasant exchanges with representatives from pharmaceutical manufacturers around the world. The participating team focused on introducing the Group’s chemical drugs, traditional Chinese medicines, big health products and medical devices to global pharmaceutical companies at the exhibition.

On October 25, 2025, the Guangzhou Huirui factory, under Yangtze River Pharmaceutical Group (the Group), successfully completed the production of two batches of Parecoxib Sodium for Injection for the UK. The products are now ready to be shipped to the UK market. This smooth delivery is not only a strong testament to the efficient collaboration of the Group's international supply chain, but also a landmark breakthrough in the Group's strategic layout for the internationalization of high-e